大家周末早安,在初冬的沪宁高铁上,我继续在旅途中编辑和发送一周文献阅读概览。
参考文献:
1. Wang J, Ni Y, Yang X, Huang G, Wei Z, Li W, Han X, Meng M, Ye X, Lei J. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity. J Cancer Res Ther. 2019;15(4):755-759. doi: 10.4103/jcrt.JCRT_399_19. PubMed PMID: 31436228.
2. Hasegawa T, Kondo C, Sato Y, Inaba Y, Yamaura H, Kato M, Murata S, Onoda Y, Kuroda H, Sakao Y, Yatabe Y. Pathologic Diagnosis and Genetic Analysis of a Lung Tumor Needle Biopsy Specimen Obtained Immediately After Radiofrequency Ablation. Cardiovasc Intervent Radiol. 2018 Apr;41(4):594-602. doi: 10.1007/s00270-017-1845-4. Epub 2017 Nov 21. PubMed PMID: 29164309.
3. Clasen S, Krober SM, Kosan B, Aebert H, Fend F, Bomches A, Claussen CD, Pereira PL. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer. 2008 Dec 1;113(11):3121-9. doi: 10.1002/cncr.23882. PubMed PMID: 18973180.
4. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings. Thorac Cardiovasc Surg. 2017 Mar;65(2):142-149. doi: 10.1055/s-0036-1572437. Epub 2016 Feb 22. PubMed PMID: 26902328.
5. Shimada Y, Ikeda N. Gap between clinical and basic researches in multifocal synchronous lung adenocarcinoma studies. J Thorac Dis 2018;10(Suppl 33):S4021-S4022. doi: 10.21037/jtd.2018.09.89
6. Gao RW, Berry MF, Kunder CA, Khuong AA, Wakelee H, Neal JW, Backhus LM, Shrager JB. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 2017 Dec;154(6):2092-2099.e2. doi: 10.1016/j.jtcvs.2017.07.034. Epub 2017 Aug 1. PubMed PMID: 28863952.
7. Chen K, Chen W, Cai J, Yang F, Lou F, Wang X, Zhang J, Zhao M, Zhang J, Wang J. Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers. J Thorac Cardiovasc Surg. 2018 Jan;155(1):371-379.e1. doi: 10.1016/j.jtcvs.2017.08.141. Epub 2017 Oct 5. PubMed PMID: 29092754.
希望对大家有所帮助
(苏州大学附属第二医院介入科 靳勇 编译)
译者简介:
国务院政府特殊津贴专家、苏州大学附属第二医院介入科主任、主任医师、医学博士、博士生导师、中国抗癌协会肿瘤消融治疗委员会常委、中国抗癌协会肿瘤介入治疗委员会委员、中国抗癌协会肺癌微创综合治疗委员会副主任委员、科技部创新产业联盟肺癌消融委员会副主任委员、江苏省抗癌协会肿瘤介入治疗委员会常委、江苏省介入医学会委员兼妇幼介入学组副组长、江苏省妇幼学会妇产介入委员会副主任委员、苏州市介入医学会副主任委员。曾荣获苏州大学优秀共产党员、苏州市卫生系统优秀共产党员、中核宝源优秀共产党员及青年文明标兵、苏州市医德医风标兵、苏大附二院“十佳”医生等称号。
专业特长:
1.肝硬化消化道大出血、顽固性腹水、门静脉血栓的介入治疗
2.肝癌、肺癌、肝血管瘤等良恶性实体肿瘤的介入微创治疗
3.食道、胃肠道、呼吸道狭窄及胆道梗阻的介入微创支架治疗
4.出血及血栓栓塞性疾病的介入微创治疗
5.子宫腺肌症、子宫肌瘤、盆腔瘀血综合征的介入治疗
6.痔疮的介入微创治疗
7.创伤性淋巴瘘的介入治疗
门诊时间:周二上午 周四上午
联系客服